OR WAIT 15 SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Jill Wechsler is Pharm Exec's Washington Corespondent
January 13, 2020
More than 200 biopharma leaders acknowledge that out-of-pocket costs for individuals must be limited to sustain support for fiscal and patent policies key to advancing innovation.
January 03, 2020
While not setting any records for the rapid approval of new drugs in 2019, FDA did speed a number of important new therapies to patients, writes Jill Wechsler.
December 12, 2019
FDA has an official new leader, following a Senate vote to confirm Stephen Hahn as the agency’s next commissioner.
October 29, 2019
CDER's Rare Disease Cures Accelerator initiative looks to foster a coordinated research approach and methods that can expedite development of drugs to treat some of the 7,000 rare diseases.